Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors

• Michael J. Breen,

  Affiliation Department of Medicine, Northwestern University, Chicago, Illinois, United States of America

  ⨯
• Diarmuid M. Moran,

  Current address: Translational R&D-Oncology, Quintiles, Westmont, Illinois, United States of America

  Affiliation Department of Medicine, Northwestern University, Chicago, Illinois, United States of America

  ⨯
• Wenzhe Liu,

  Affiliation Department of Medicine, Northwestern University, Chicago, Illinois, United States of America

  ⨯
• Xiaoke Huang,

  Affiliation Department of Medicine, Northwestern University, Chicago, Illinois, United States of America

  ⨯
• Calvin P. H. Vary,

  Affiliation Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine, United States of America

  ⨯
• Raymond C. Bergan

  * E-mail: r-bergan@northwestern.edu

  Affiliations Department of Medicine, Northwestern University, Chicago, Illinois, United States of America, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, United States of America, Center for Molecular Innovation and Drug Discovery, Northwestern University, Chicago, Illinois, United States of America

  ⨯